Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 3
Submit an article Journal homepage
4,233
Views
67
CrossRef citations to date
0
Altmetric
Original Research

Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer

Dang WuCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Pin WuCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China;Department of Thoracic Surgery; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Xianguo WuDepartment of Clinical Laboratory; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Jun YeCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Gastroenterology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Zhen WangCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Shuai ZhaoCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Chao NiCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Guoming HuCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Jinghong XuDepartment of Pathology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University; Hangzhou, China
,
Yuehua HanDepartment of Gastroenterology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Ting ZhangDepartment of Radiation Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Fuming QiuCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, China
,
Jun YanDepartment of Medicine and Department of Microbiology and Immunology; James Graham Brown Cancer Center; University of Louisville; Louisville, KY, USACorrespondence[email protected] [email protected]
&
Jian HuangCancer Institute (Key Laboratory of Cancer Prevention & Intervention; National Ministry of Education; Provincial Key Laboratory of Molecular Biology in Medical Sciences), Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, China;Department of Oncology; Second Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang University, Hangzhou, ChinaCorrespondence[email protected] [email protected]
 show all
Article: e992749 | Received 30 Sep 2014, Accepted 25 Nov 2014, Published online: 02 Apr 2015

Citations (67)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Huimin Lu, Tongguo Shi, Mingyuan Wang, Xiaomi Li, Yanzheng Gu, Xueguang Zhang, Guangbo Zhang & Weichang Chen. (2020) B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells. OncoImmunology 9:1.
Read now
Elena Lo Presti, Anna Maria Corsale, Francesco Dieli & Serena Meraviglia. (2019) γδ cell-based immunotherapy for cancer. Expert Opinion on Biological Therapy 19:9, pages 887-895.
Read now
Kyle K. Payne. (2016) Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy. Immunological Investigations 45:8, pages 767-775.
Read now

Articles from other publishers (64)

Wenyi Yan, Louisa S. Chard Dunmall, Nicholas R. Lemoine, Yaohe Wang, Yafeng Wang & Pengju Wang. (2023) The capability of heterogeneous γδ T cells in cancer treatment. Frontiers in Immunology 14.
Crossref
Peizhe Lin, Yijing Yan, Ze Zhang, Qiutong Dong, Jia Yi, Qingbo Li, Ao Zhang & Xianbin Kong. (2023) The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study. International Immunopharmacology 123, pages 110733.
Crossref
Wei Luo, Xiaohong Bian, Xiaona Liu, Wenchao Zhang, Qing Xie & Limin Feng. (2023) A new method for the treatment of myocardial ischemia-reperfusion injury based on γδT cell-mediated immune response. Frontiers in Cardiovascular Medicine 10.
Crossref
Ziwen Zheng, Thomas Wieder, Bernhard Mauerer, Luisa Schäfer, Rebecca Kesselring & Heidi Braumüller. (2023) T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment. International Journal of Molecular Sciences 24:14, pages 11673.
Crossref
Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, Joanna Mikulak & Domenico Mavilio. (2023) NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy. Cancers 15:4, pages 1264.
Crossref
Wenkang Niu, Tingting Zhang & Lei Ma. (2023) Correlation analysis between immune-related genes and cell infiltration revealed prostate cancer immunotherapy biomarkers linked to T cells gamma delta. Scientific Reports 13:1.
Crossref
Anna Maria Corsale, Marta Di Simone, Elena Lo Presti, Francesco Dieli & Serena Meraviglia. (2023) γδ T cells and their clinical application in colon cancer. Frontiers in Immunology 14.
Crossref
Natasja L. de Vries, Joris van de Haar, Vivien Veninga, Myriam Chalabi, Marieke E. Ijsselsteijn, Manon van der Ploeg, Jitske van den Bulk, Dina Ruano, Jose G. van den Berg, John B. Haanen, Laurien J. Zeverijn, Birgit S. Geurts, Gijs F. de Wit, Thomas W. Battaglia, Hans Gelderblom, Henk M. W. Verheul, Ton N. Schumacher, Lodewyk F. A. Wessels, Frits Koning, Noel F. C. C. de Miranda & Emile E. Voest. (2023) γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 613:7945, pages 743-750.
Crossref
Zhicheng Du, Sumin Zhu, Xi Zhang, Zhiyuan Gong & Shu Wang. (2023) Non-Conventional Allogeneic Anti-BCMA Chimeric Antigen Receptor-Based Immune Cell Therapies for Multiple Myeloma Treatment. Cancers 15:3, pages 567.
Crossref
Laura A. Ridgley, Jonathan Caron, Angus Dalgleish & Mark Bodman-Smith. (2023) Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy. Frontiers in Immunology 13.
Crossref
Renhong Zhu, Qian Yan, Yashu Wang & Keqiang Wang. (2023) Biological characteristics of γδT cells and application in tumor immunotherapy. Frontiers in Genetics 13.
Crossref
Vasudevaraju Padmaraju, Yogitha Sankla & Rama Rao Malla. (2023) Role of γδ T Cells in Cancer Progression and Therapy. Critical Reviews™ in Oncogenesis 28:4, pages 59-70.
Crossref
Jing-Yu He, Fang-Yi Huo, Hong-Chao Tang, Bing Liu & Lin-Lin Bu. 2023. Myeloid-derived suppressor cells. Myeloid-derived suppressor cells 33 92 .
Di Chen, Yinglu Guo, Jiahuan Jiang, Pin Wu, Ting Zhang, Qichun Wei, Jian Huang & Dang Wu. (2022) γδ T cell exhaustion: Opportunities for intervention. Journal of Leukocyte Biology 112:6, pages 1669-1676.
Crossref
Xiomar Bustos, Sebastian Snedal, Leticia Tordesillas, Eleonora Pelle & Daniel Abate-Daga. (2022) γδ T Cell–Based Adoptive Cell Therapies Against Solid Epithelial Tumors. The Cancer Journal 28:4, pages 270-277.
Crossref
Salomon Manier, Tiziano Ingegnere, Guillaume Escure, Chloé Prodhomme, Morgane Nudel, Suman Mitra & Thierry Facon. (2022) Current state and next-generation CAR-T cells in multiple myeloma. Blood Reviews 54, pages 100929.
Crossref
José Saura-Esteller, Milon de Jong, Lisa A. King, Erik Ensing, Benjamin Winograd, Tanja D. de Gruijl, Paul W. H. I. Parren & Hans J. van der Vliet. (2022) Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future. Frontiers in Immunology 13.
Crossref
Yuan Song, Yonghao Liu, Huey Yee Teo & Haiyan Liu. (2022) Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Gabrielle M. Ferry, Charles Agbuduwe, Megan Forrester, Sophie Dunlop, Kerry Chester, Jonathan Fisher, John Anderson & Marta Barisa. (2022) A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Eugene Y Chiang & Ira Mellman. (2022) TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 10:4, pages e004711.
Crossref
Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A.K. M. Mohiuddin, Long Chiau Ming, Khang Wen Goh & Muhammad Abdul Hadi. (2022) Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers 14:7, pages 1732.
Crossref
Huidi Wang, Jie Li, Yan He & Jia Yin. (2022) The microbiota is a potential mediator of the crosstalk between γδ T cells and tumors. Exploration of Immunology, pages 48-63.
Crossref
Michał K. Zarobkiewicz & Agnieszka A. Bojarska-Junak. (2022) The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL). Cells 11:4, pages 661.
Crossref
Fengyun Zhong, Yilin Lin, Xiangxiang Jing, Yingjiang Ye, Shan Wang & Zhanlong Shen. (2022) Innate tumor killers in colorectal cancer. Cancer Letters 527, pages 115-126.
Crossref
Paulina Atieno Duya, Yinxiao Chen, Liding Bai, Zhaodong Li, Jiaying Li, Rundong Chai, Yuhong Bian & Shuwu Zhao. (2022) Nature products of traditional Chinese medicine provide new ideas in γδT cell for tumor immunotherapy. Acupuncture and Herbal Medicine 2:2, pages 78-83.
Crossref
Abed El-Hakim El-Kadiry, Moutih Rafei & Riam Shammaa. (2021) Cell Therapy: Types, Regulation, and Clinical Benefits. Frontiers in Medicine 8.
Crossref
Shine-Gwo Shiah, Sung-Tau Chou & Jang-Yang Chang. (2021) MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma. Cancers 13:22, pages 5604.
Crossref
Mateus de Souza Barros, Nilberto Dias de Araújo, Fábio Magalhães-Gama, Thaís Lohana Pereira Ribeiro, Fabíola Silva Alves Hanna, Andréa Monteiro Tarragô, Adriana Malheiro & Allyson Guimarães Costa. (2021) γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. Frontiers in Immunology 12.
Crossref
Long Yu, Yang Zhang, Jinfeng Xiong, Jianjun Liu, Ying Zha, Qi Kang, Pan Zhi, Qiang Wang, Hui Wang, Wanjiang Zeng & Yafei Huang. (2021) Activated γδ T Cells With Higher CD107a Expression and Inflammatory Potential During Early Pregnancy in Patients With Recurrent Spontaneous Abortion. Frontiers in Immunology 12.
Crossref
Rueyhung R. Weng, Hsuan-Hsuan Lu, Chien-Ting Lin, Chia-Chi Fan, Rong-Shan Lin, Tai-Chung Huang, Shu-Yung Lin, Yi-Jhen Huang, Yi-Hsiu Juan, Yi-Chieh Wu, Zheng-Ci Hung, Chi Liu, Xuan-Hui Lin, Wan-Chen Hsieh, Tzu-Yuan Chiu, Jung-Chi Liao, Yen-Ling Chiu, Shih-Yu Chen, Chong-Jen Yu & Hsing-Chen Tsai. (2021) Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nature Communications 12:1.
Crossref
Yongting Liu, Ying Han, Shan Zeng & Hong Shen. (2021) In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity. Cell & Bioscience 11:1.
Crossref
Yang Li, Gen Li, Jian Zhang, Xiaoli Wu & Xi Chen. (2021) The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting. Frontiers in Immunology 11.
Crossref
Shenqi Han, Yongqiang Qi, Yiming Luo, Xiaoping Chen & Huifang Liang. (2021) Exosomal Long Non-Coding RNA: Interaction Between Cancer Cells and Non-Cancer Cells. Frontiers in Oncology 10.
Crossref
Rebecca E. Burnham, Jaquelyn T. Zoine, Jamie Y. Story, Swetha N. Garimalla, Greg Gibson, Aaron Rae, Erich Williams, Lisa Bixby, David Archer, Christopher B. Doering & H. Trent Spencer. (2020) Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy. Frontiers in Medicine 7.
Crossref
Cynthia Perez, Isabelle Gruber & Caroline Arber. (2020) Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells. Frontiers in Immunology 11.
Crossref
Hannah Kaminski, Gabriel Marsères, Anaïs Cosentino, Florent Guerville, Vincent Pitard, Jean‐Jacques Fournié, Pierre Merville, Julie Déchanet‐Merville & Lionel Couzi. (2020) Understanding human γδ T cell biology toward a better management of cytomegalovirus infection. Immunological Reviews 298:1, pages 264-288.
Crossref
Toshiyasu Suzuki, Liam Hayman, Anna Kilbey, Joanne Edwards & Seth B. Coffelt. (2020) Gut γδ T cells as guardians, disruptors, and instigators of cancer. Immunological Reviews 298:1, pages 198-217.
Crossref
Rulan Ma, Dawei Yuan, Yizhan Guo, Rong Yan & Kang Li. (2020) Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Frontiers in Immunology 11.
Crossref
Dieter Kabelitz, Ruben Serrano, Léonce Kouakanou, Christian Peters & Shirin Kalyan. (2020) Cancer immunotherapy with γδ T cells: many paths ahead of us. Cellular & Molecular Immunology 17:9, pages 925-939.
Crossref
Chi Li, Howard Donninger, John Eaton & Kavitha Yaddanapudi. (2020) Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope. Frontiers in Immunology 11.
Crossref
Mahboubeh Yazdanifar, Giulia Barbarito, Alice Bertaina & Irma Airoldi. (2020) γδ T Cells: The Ideal Tool for Cancer Immunotherapy. Cells 9:5, pages 1305.
Crossref
Jennifer A. Juno & Stephen J. Kent. (2020) What Can Gamma Delta T Cells Contribute to an HIV Cure?. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Yuxia Liu & Cai Zhang. (2020) The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy. Cells 9:5, pages 1206.
Crossref
Chao Ni, Qing-Qing Fang, Wu-Zhen Chen, Jin-Xing Jiang, Zhou Jiang, Jun Ye, Ting Zhang, Liu Yang, Fan-Bo Meng, Wen-Jie Xia, Miaochun Zhong & Jian Huang. (2020) Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells. Signal Transduction and Targeted Therapy 5:1.
Crossref
Forrest L. Baker, Austin B. Bigley, Nadia H. Agha, Charles R. Pedlar, Daniel P. O'Connor, Richard A. Bond, Catherine M. Bollard, Emmanuel Katsanis & Richard J. Simpson. (2020) Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells. Frontiers in Immunology 10.
Crossref
Donatella Lucchetti, Claudio Ricciardi Tenore, Filomena Colella & Alessandro Sgambato. (2020) Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity. Cancers 12:1, pages 171.
Crossref
Hye Won Lee, Yun Shin Chung & Tae Jin Kim. (2020) Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity. Immune Network 20:1.
Crossref
Jérôme Galon & Daniela Bruni. (2020) Tumor Immunology and Tumor Evolution: Intertwined Histories. Immunity 52:1, pages 55-81.
Crossref
Oliver Nussbaumer & Michael Koslowski. (2019) The emerging role of γδ T cells in cancer immunotherapy. Immuno-Oncology Technology 1, pages 3-10.
Crossref
Ling Li, Bangrong Cao, Xinhua Liang, Shun Lu, Huaichao Luo, Zhaohui Wang, Shaoxin Wang, Jian Jiang, Jinyi Lang & Guiquan Zhu. (2018) Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes. Oncogene 38:15, pages 2830-2843.
Crossref
Ling Li, Shun Lu, Xinhua Liang, Bangrong Cao, Shaoxin Wang, Jian Jiang, Huaichao Luo, Shuya He, Jinyi Lang & Guiquan Zhu. (2019) γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma. Molecular Therapy - Nucleic Acids 14, pages 101-113.
Crossref
Mathilde Raverdeau, Stephen P Cunningham, Cathal Harmon & Lydia Lynch. (2019) γδ T cells in cancer: a small population of lymphocytes with big implications. Clinical & Translational Immunology 8:10.
Crossref
Ankita Tiwari, Shivani Saraf, Amit Verma, Pritish Kumar Panda & Sanjay K Jain. (2018) Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World Journal of Gastroenterology 24:39, pages 4428-4435.
Crossref
C. David Pauza, Mei-Ling Liou, Tyler Lahusen, Lingzhi Xiao, Rena G. Lapidus, Cristiana Cairo & Haishan Li. (2018) Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Frontiers in Immunology 9.
Crossref
Xian Chen, Jie-xin Zhang, Wen-wen Shang, Wei-ping Xie, Shu-xian Jin & Fang Wang. (2018) Aberrant Peripheral Immune Function in a Good Syndrome Patient. Journal of Immunology Research 2018, pages 1-10.
Crossref
Elena Lo Presti, Gabriele Pizzolato, Eliana Gulotta, Gianfranco Cocorullo, Gaspare Gulotta, Francesco Dieli & Serena Meraviglia. (2017) Current Advances in γδ T Cell-Based Tumor Immunotherapy. Frontiers in Immunology 8.
Crossref
Yi Bao, Li Guo & Juanfen Mo. (2017) Characterization of γδ T cells in patients with non-small cell lung cancer. Oncology Letters 14:1, pages 1133-1140.
Crossref
Dang Wu, Pin Wu, Fuming Qiu, Qichun Wei & Jian Huang. (2016) Human γδT-cell subsets and their involvement in tumor immunity. Cellular & Molecular Immunology 14:3, pages 245-253.
Crossref
Malgorzata Krzystek-Korpacka, Marek Zawadzki, Katarzyna Neubauer, Iwona Bednarz-Misa, Sabina Górska, Jerzy Wiśniewski, Wojciech Witkiewicz & Andrzej Gamian. (2016) Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon. Cancer Immunology, Immunotherapy 66:2, pages 171-179.
Crossref
Afonso R. Almeida, Daniel V. Correia, Ana Fernandes-Platzgummer, Cláudia L. da Silva, Maria Gomes da Silva, Diogo Remechido Anjos & Bruno Silva-Santos. (2016) Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept. Clinical Cancer Research 22:23, pages 5795-5804.
Crossref
F. Hua, L. Wang, X. Rong, Y. Hu, J. M. Zhang, W. He & F. C. Zhang. (2016) Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis. Clinical & Experimental Immunology 186:3, pages 347-355.
Crossref
Han Lu, Da-Jin Li & Li-Ping Jin. (2016) γδT Cells and Related Diseases. American Journal of Reproductive Immunology 75:6, pages 609-618.
Crossref
Xuan Sun, Jian Suo & Jun Yan. (2016) Immunotherapy in human colorectal cancer: Challenges and prospective. World Journal of Gastroenterology 22:28, pages 6362.
Crossref
Fan Yang, Hao Jin, Jian Wang, Qian Sun, Cihui Yan, Feng Wei & Xiubao Ren. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy 169 239 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.